Cornerstone Capital Management Holdings LLC. Reduces Position in Catalent Inc (CTLT)

Cornerstone Capital Management Holdings LLC. cut its position in shares of Catalent Inc (NASDAQ:CTLT) by 41.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 163,244 shares of the company’s stock after selling 116,100 shares during the quarter. Cornerstone Capital Management Holdings LLC. owned about 0.13% of Catalent worth $5,729,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CTLT. Russell Investments Group Ltd. boosted its position in shares of Catalent by 31.0% during the first quarter. Russell Investments Group Ltd. now owns 20,891 shares of the company’s stock valued at $591,000 after purchasing an additional 4,943 shares in the last quarter. Karp Capital Management Corp bought a new stake in shares of Catalent during the first quarter valued at approximately $648,000. Parametric Portfolio Associates LLC boosted its position in shares of Catalent by 12.3% during the first quarter. Parametric Portfolio Associates LLC now owns 153,781 shares of the company’s stock valued at $4,355,000 after purchasing an additional 16,856 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Catalent by 13.5% during the first quarter. Envestnet Asset Management Inc. now owns 27,181 shares of the company’s stock valued at $769,000 after purchasing an additional 3,237 shares in the last quarter. Finally, Stifel Financial Corp boosted its position in shares of Catalent by 14.3% during the first quarter. Stifel Financial Corp now owns 10,598 shares of the company’s stock valued at $300,000 after purchasing an additional 1,329 shares in the last quarter.

In other news, SVP Christine Dolan sold 1,594 shares of the firm’s stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $38.75, for a total value of $61,767.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

ILLEGAL ACTIVITY WARNING: “Cornerstone Capital Management Holdings LLC. Reduces Position in Catalent Inc (CTLT)” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://sportsperspectives.com/2017/10/12/cornerstone-capital-management-holdings-llc-reduces-position-in-catalent-inc-ctlt.html.

A number of research analysts have issued reports on CTLT shares. Zacks Investment Research cut Catalent from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Bank of America Corporation reiterated a “buy” rating and set a $40.00 price objective (up previously from $38.00) on shares of Catalent in a research note on Tuesday, August 29th. Piper Jaffray Companies reiterated a “buy” rating and set a $45.00 price objective on shares of Catalent in a research note on Tuesday, August 29th. William Blair reiterated an “ourperform” rating on shares of Catalent in a research note on Tuesday, August 29th. Finally, ValuEngine upgraded Catalent from a “hold” rating to a “buy” rating in a research note on Thursday, September 7th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $38.64.

Catalent Inc (NASDAQ:CTLT) opened at 42.94 on Thursday. Catalent Inc has a 1-year low of $21.83 and a 1-year high of $42.96. The stock has a market cap of $5.38 billion and a PE ratio of 49.36. The stock has a 50 day moving average price of $40.10 and a 200 day moving average price of $35.13.

Catalent (NASDAQ:CTLT) last announced its earnings results on Monday, August 28th. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.08. The business had revenue of $616.90 million for the quarter, compared to analysts’ expectations of $547.48 million. Catalent had a return on equity of 36.29% and a net margin of 10.02%. The business’s revenue for the quarter was up 15.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.52 EPS. On average, analysts predict that Catalent Inc will post $1.62 EPS for the current fiscal year.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Institutional Ownership by Quarter for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply